The transformative ability of all ALL-associated JAK2 mutations are dependent on cytokine receptor association, suggesting that these mutations are dependent on JAK2 dimerization (Lu et al., 2008; Wernig et al., 2008; Yao et al., 2017; Hammaren et al., 2019b). This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.